CYCLOLUX

This brand name is authorized in Austria, Croatia, Ecuador, Estonia, Lithuania, Poland, Romania, Spain.

Active ingredients

The drug CYCLOLUX contains one active pharmaceutical ingredient (API):

1
UNII QVF9Y6955W - GADOTERIC ACID
 

Gadoteric acid has paramagnetic properties allowing MRI contrast enhancement. It has no specific pharmacodynamic activity and is biologically very inert.
 
Read more about Gadoteric acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V08CA02 Gadoteric acid V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 7243-MEE-0522
EE Ravimiamet 1868261, 1868272, 1868283, 1868294, 1868306, 1868317
ES Centro de información online de medicamentos de la AEMPS 80133, 80134
HR Agencija za lijekove i medicinske proizvode HR-H-062832318
LT Valstybinė vaistų kontrolės tarnyba 1083237, 1083238, 1083239, 1083240, 1083241, 1083242, 1085828, 1085829, 1085830, 1085831
PL Rejestru Produktów Leczniczych 100346161, 100346178
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W69316001, W69316002, W69316003, W69316004, W69316005, W69316006

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈